Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Convertible Debt (2016 - 2019)

Historic Convertible Debt for Sanara MedTech (SMTI) over the last 9 years, with Q4 2019 value amounting to $1.5 million.

  • Sanara MedTech's Convertible Debt changed N/A to $1.5 million in Q4 2019 from the same period last year, while for Dec 2019 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2019, which is N/A changed from last year.
  • Latest data reveals that Sanara MedTech reported Convertible Debt of $1.5 million as of Q4 2019.
  • Sanara MedTech's 5-year Convertible Debt high stood at $1.5 million for Q3 2018, and its period low was $1.2 million during Q4 2015.
  • In the last 5 years, Sanara MedTech's Convertible Debt had a median value of $1.2 million in 2015 and averaged $1.3 million.
  • Examining YoY changes over the last 5 years, Sanara MedTech's Convertible Debt showed a top increase of 0.0% in 2016 and a maximum decrease of 0.0% in 2016.
  • Quarter analysis of 5 years shows Sanara MedTech's Convertible Debt stood at $1.2 million in 2015, then changed by 0.0% to $1.2 million in 2016, then changed by 0.0% to $1.2 million in 2017, then rose by 25.0% to $1.5 million in 2018, then changed by 0.0% to $1.5 million in 2019.
  • Its last three reported values are $1.5 million in Q4 2019, $1.5 million for Q3 2019, and $1.5 million during Q2 2019.